NCT05100758View on ClinicalTrials.gov

Active Hexose Correlated Compound in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 1, 2020

Study Completion Date

December 1, 2020

Conditions
TuberculosisHuman Immunodeficiency Virus
Interventions
DIETARY_SUPPLEMENT

Active Hexoses Correlated Compound

Active Hexose Correlated Compound was isolated from basidiomycetes which comprise polysaccharides and amino acids.

Trial Locations (1)

90132

Labuang Baji General Hospital, Makassar

All Listed Sponsors
lead

Hasanuddin University

OTHER

NCT05100758 - Active Hexose Correlated Compound in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection | Biotech Hunter | Biotech Hunter